About US
Contact us
-
Biotie and Merck turn their backs on NewronFinland's Biotie Therapies has pulled out of its planned merger with Newron Pharmaceuticals following a decision by Merck to return the full global rights to investigational Parkinson's disease drug s2011/11/2
-
Obama orders FDA to tackle drug shortageUS President Barack Obama has ordered the Food and Drug Administration (FDA) to remedy the problem of drug shortages in the country. Over the past year, the majority of hospitals in the US have been2011/11/2
-
Merck net income rise on key drug performanceMerck & Cohas reported a surge in third quarter net income, based on strong sales of key drugs, including Januvia, Janumet and Gardasil. Diabetes medications Januvia and Janumet reported sales in2011/11/2
-
Bristol-Myers Squibb reports strong revenue riseBristol-Myers Squibb (BMS) has reported strong third quarter results, announcing an 11% increase in revenue to $5.35bn attributed to the company's blood thinning drug Plavix. Plavix turnover rose 8%2011/11/2
-
SFDA Commissioner Shao Mingli meets Director General of the Center for Genetic Engineering and Biotechnology of CubaOn October 28, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA), met with the visiting delegation led by the Director General of the Center for Genetic Engineering2011/11/1
-
SFDA issues the Third Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 2011SFDA issues the Third Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 20112011/11/1
-
Crestor drives AstraZeneca financialsAstraZeneca cholesterol drug Crestor drove the company's third-quarter financials forward as generic competition significantly affected other medications. Although revenues fell 2% to approximately $2011/11/1
-
SFDA Commissioner Shao Mingli meets Belgian Vice Prime Minister and Minister of Foreign Affairs and Institutional ReformOn October 24, 2011, the Belgian delegation led by Mr. Steven Vanackere, Vice Prime Minister and Minister of Foreign Affairs and Institutional Reform of Belgium, visited the State Food and Drug Admini2011/10/28
-
EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13Pfizer Inc. (NYSE: PFE) announced today that the European Commission has approved the Company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, a2011/10/28
-
Scientists, WHO warn of public health implications of proposed mercury ban due to its use in vaccines"Scientists are warning officials negotiating a global treaty on mercury that banning the deadly chemical completely would be dangerous for public health because of the chemical's use invaccines," the2011/10/25